James Julius Morrow, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteosarcoma | 4 | 2019 | 880 | 1.240 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2018 | 1337 | 0.600 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 2107 | 0.290 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 2699 | 0.260 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 3639 | 0.260 |
Why?
|
| Myofibromatosis | 1 | 2023 | 30 | 0.220 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2522 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 8425 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 5522 | 0.190 |
Why?
|
| RNA, Messenger | 1 | 2016 | 13029 | 0.190 |
Why?
|
| Transcription Factor AP-1 | 2 | 2018 | 317 | 0.170 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 16665 | 0.150 |
Why?
|
| Lung Neoplasms | 3 | 2019 | 13019 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2017 | 3557 | 0.140 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2017 | 166 | 0.140 |
Why?
|
| Thromboplastin | 1 | 2018 | 291 | 0.140 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2019 | 670 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 2 | 2017 | 2723 | 0.140 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 4839 | 0.130 |
Why?
|
| Epigenomics | 2 | 2018 | 902 | 0.130 |
Why?
|
| Mice, SCID | 2 | 2019 | 2715 | 0.120 |
Why?
|
| Ependymoma | 1 | 2017 | 333 | 0.120 |
Why?
|
| Mice, Nude | 2 | 2017 | 3689 | 0.110 |
Why?
|
| Selection, Genetic | 1 | 2018 | 914 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2014 | 220 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1372 | 0.100 |
Why?
|
| Oncogenes | 1 | 2017 | 1263 | 0.100 |
Why?
|
| Tumor Microenvironment | 3 | 2019 | 3564 | 0.100 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 768 | 0.100 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2014 | 384 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 1707 | 0.080 |
Why?
|
| Sirolimus | 1 | 2016 | 1562 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2017 | 2572 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 6382 | 0.070 |
Why?
|
| Indoles | 1 | 2014 | 1834 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2017 | 10472 | 0.070 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2014 | 1255 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2014 | 1932 | 0.060 |
Why?
|
| Genome, Human | 1 | 2018 | 4420 | 0.060 |
Why?
|
| Proteomics | 1 | 2016 | 3618 | 0.060 |
Why?
|
| Proteins | 1 | 2018 | 6096 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2023 | 188 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2017 | 3456 | 0.050 |
Why?
|
| Mice | 6 | 2019 | 81045 | 0.050 |
Why?
|
| Animals | 7 | 2019 | 168561 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 4438 | 0.050 |
Why?
|
| Apoptosis | 1 | 2016 | 9715 | 0.040 |
Why?
|
| Cytokines | 1 | 2014 | 7317 | 0.040 |
Why?
|
| Germ Cells | 1 | 2023 | 628 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3731 | 0.040 |
Why?
|
| Phenotype | 1 | 2016 | 16331 | 0.040 |
Why?
|
| RNA Interference | 2 | 2017 | 2890 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2016 | 23387 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2017 | 12164 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6754 | 0.040 |
Why?
|
| Cell Survival | 2 | 2017 | 5872 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 731 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 808 | 0.040 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 182 | 0.030 |
Why?
|
| Mutation | 3 | 2017 | 29717 | 0.030 |
Why?
|
| Melanoma | 1 | 2014 | 5462 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 553 | 0.030 |
Why?
|
| Humans | 10 | 2023 | 742088 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2014 | 1683 | 0.020 |
Why?
|
| Female | 6 | 2019 | 379592 | 0.020 |
Why?
|
| Genomics | 1 | 2023 | 5692 | 0.020 |
Why?
|
| Base Sequence | 1 | 2017 | 12797 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4187 | 0.020 |
Why?
|
| Chromatin | 1 | 2017 | 2917 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 2028 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 7721 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 9735 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 11363 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13256 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 21821 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18006 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39004 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 77098 | 0.000 |
Why?
|
| Aged | 1 | 2014 | 162944 | 0.000 |
Why?
|
| Male | 1 | 2017 | 349538 | 0.000 |
Why?
|